Status:
UNKNOWN
Effect of Ultrasound-guided Transversus Abdominis Plane Block After Laparoscopic Bariatric Surgery
Lead Sponsor:
Tianjin Medical University General Hospital
Conditions:
Postoperative Nausea and Vomiting
Postoperative Pain
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
To explore and compare Ultrasound-Guided Transversus Abdominis Plane Block on Postoperative nausea and vomiting and Early Outcome After Laparoscopic Bariatric Surgery To evaluate and examine TAPB can ...
Detailed Description
Poor postoperative nausea and vomiting control is a leading factor that hinders the physical rehabilitation, and causes acute cognitive impairment and chronic pain syndrome. Recently, the multimodal a...
Eligibility Criteria
Inclusion
- Subject is scheduled to undergo Laparoscopic Bariatric Surgery
- Subject's American Society of Anesthesiologists physical status is I-III.
- BMI\>35kg/m2
- The subject's parent/legally authorized guardian has given written informed consent to participate
Exclusion
- Subject has a diagnosis of renal or liver failure.
- Subject has a diagnosis of mental illness
- Subject is allergy and contraindication to Ropivacaine.
- Subject has a history of chronic pain, a history of alcohol or opioid abuse, pre-existing therapy with opioids, intake of any analgesic drug within 48 hours before surgery.
- Subject has any contraindication for the use
- Subject is pregnant or breast-feeding.
Key Trial Info
Start Date :
March 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 15 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05286008
Start Date
March 18 2022
End Date
October 15 2022
Last Update
March 18 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.